Vishal Mega Mart Falls 7% After ₹7,915 Crore Block Deals
Vishal Mega Mart shares came under pressure after block deals worth ₹7,915 crore were executed in multiple transactions. The large-scale […]
CDSL’s Growth Story: From 1999 Roots to Market Leadership
In India’s financial markets, trust is not built overnight. It is earned transaction by transaction, year after year. The story of Central Depository Services (India) Limited, or CDSL, is a powerful example of how patient institution building, smart technology adoption, and deep understanding of investor needs can create a market leader that becomes part of a nation’s financial culture.
At $380 Billion, Anthropic’s valuation is more than the combined market cap of the top Indian IT Stocks
Introduction A $380 billion valuation is enough to turn heads anywhere in the world. When that valuation belongs to an
AI Doomsday Report Flags Disruption Risks for Infosys, TCS, and Wipro
Introduction: Why the AI Doomsday Narrative Is Grabbing Attention A recent AI doomsday-style report has triggered intense debate across global
Shree Ram Twistex IPO Day 3: Latest Subscription Status and Allotment Timeline
Introduction: Why Day 3 of the IPO Is Crucial The final day of an IPO often sets the tone for
TCS, Infosys, HCLTech Drag NIFTY IT Down 21%
Introduction: Why the Fall in IT Stocks Matters Now India’s information technology sector has long been seen as a pillar
Clean Max Enviro Energy vs Shree Ram Twistex IPO: Where to Invest?
The IPO market often puts investors in a familiar dilemma. When two very different businesses tap the market around the
9 Sensex Stocks With Up to 40% Upside Potential – Are These in Your Portfolio?
Indian equity markets have seen sharp swings over the past year, testing the patience of even seasoned investors. Amid this
Top 10 tax-free income sources in India in 2026
As tax rules evolve and incomes rise, Indian investors are paying closer attention to how much of their earnings they
Emcure Pharmaceuticals reports growth outpacing the industry across all markets
At a time when the pharmaceutical sector is navigating pricing pressure, regulatory scrutiny, and uneven global demand, Emcure Pharmaceuticals has